Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium inhaler crossover PK study in COPD
2012-003413-33Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of tiotropium in chronic obstructive pulmonary disease (COPD) (4 arms), sponsored by Teva Pharmaceutical Industries Ltd. Primary endpoint: Primary pharmacokinetic outcome measures. Started Sep 2012; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2012-003413-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003413-33.